146 related articles for article (PubMed ID: 35177646)
41. ErbB3 inhibitory surrobodies inhibit tumor cell proliferation in vitro and in vivo.
Foreman PK; Gore M; Kobel PA; Xu L; Yee H; Hannum C; Ho H; Wang SM; Tran HV; Horowitz M; Horowitz L; Bhatt RR
Mol Cancer Ther; 2012 Jul; 11(7):1411-20. PubMed ID: 22553357
[TBL] [Abstract][Full Text] [Related]
42. Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathway.
Ohnishi Y; Yasui H; Kakudo K; Nozaki M
Oncol Rep; 2016 Nov; 36(5):3058-3064. PubMed ID: 27633099
[TBL] [Abstract][Full Text] [Related]
43. GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation.
Hassan G; Afify SM; Zahra MH; Nawara HM; Kumon K; Iwasaki Y; Salomon DS; Seno A; Seno M
Cytotechnology; 2023 Jun; 75(3):243-253. PubMed ID: 37181678
[TBL] [Abstract][Full Text] [Related]
44. MET and ERBB2 are coexpressed in ERBB2+ breast cancer and contribute to innate resistance.
Paulson AK; Linklater ES; Berghuis BD; App CA; Oostendorp LD; Paulson JE; Pettinga JE; Melnik MK; Vande Woude GF; Graveel CR
Mol Cancer Res; 2013 Sep; 11(9):1112-21. PubMed ID: 23825050
[TBL] [Abstract][Full Text] [Related]
45. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
[TBL] [Abstract][Full Text] [Related]
46. A model of cancer stem cells derived from mouse induced pluripotent stem cells.
Chen L; Kasai T; Li Y; Sugii Y; Jin G; Okada M; Vaidyanath A; Mizutani A; Satoh A; Kudoh T; Hendrix MJ; Salomon DS; Fu L; Seno M
PLoS One; 2012; 7(4):e33544. PubMed ID: 22511923
[TBL] [Abstract][Full Text] [Related]
47. Tumor-associated macrophages derived from cancer stem cells.
Osman A; Oze M; Afify SM; Hassan G; El-Ghlban S; Nawara HM; Fu X; Zahra MH; Seno A; Winer I; Salomon DS; Seno M
Acta Histochem; 2020 Dec; 122(8):151628. PubMed ID: 32992123
[TBL] [Abstract][Full Text] [Related]
48. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
49. Chronic morphine treatment attenuates cell growth of human BT474 breast cancer cells by rearrangement of the ErbB signalling network.
Weingaertner IR; Koutnik S; Ammer H
PLoS One; 2013; 8(1):e53510. PubMed ID: 23308242
[TBL] [Abstract][Full Text] [Related]
50. Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling.
Young CD; Pfefferle AD; Owens P; Kuba MG; Rexer BN; Balko JM; Sánchez V; Cheng H; Perou CM; Zhao JJ; Cook RS; Arteaga CL
Cancer Res; 2013 Jul; 73(13):4075-85. PubMed ID: 23633485
[TBL] [Abstract][Full Text] [Related]
51. Targeting ErbB3-mediated stromal-epithelial interactions in pancreatic ductal adenocarcinoma.
Liles JS; Arnoletti JP; Kossenkov AV; Mikhaylina A; Frost AR; Kulesza P; Heslin MJ; Frolov A
Br J Cancer; 2011 Aug; 105(4):523-33. PubMed ID: 21792199
[TBL] [Abstract][Full Text] [Related]
52. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.
Bruzzese F; Leone A; Rocco M; Carbone C; Piro G; Caraglia M; Di Gennaro E; Budillon A
J Cell Physiol; 2011 Sep; 226(9):2378-90. PubMed ID: 21660961
[TBL] [Abstract][Full Text] [Related]
53. ErbB2 and p38γ MAPK mediate alcohol-induced increase in breast cancer stem cells and metastasis.
Xu M; Ren Z; Wang X; Comer A; Frank JA; Ke ZJ; Huang Y; Zhang Z; Shi X; Wang S; Luo J
Mol Cancer; 2016 Jul; 15(1):52. PubMed ID: 27416801
[TBL] [Abstract][Full Text] [Related]
54. p63 Sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling.
Memmi EM; Sanarico AG; Giacobbe A; Peschiaroli A; Frezza V; Cicalese A; Pisati F; Tosoni D; Zhou H; Tonon G; Antonov A; Melino G; Pelicci PG; Bernassola F
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3499-504. PubMed ID: 25739959
[TBL] [Abstract][Full Text] [Related]
55. ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.
Capparelli C; Purwin TJ; Heilman SA; Chervoneva I; McCue PA; Berger AC; Davies MA; Gershenwald JE; Krepler C; Aplin AE
Cancer Res; 2018 Oct; 78(19):5680-5693. PubMed ID: 30115691
[TBL] [Abstract][Full Text] [Related]
56. Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells.
Erjala K; Sundvall M; Junttila TT; Zhang N; Savisalo M; Mali P; Kulmala J; Pulkkinen J; Grenman R; Elenius K
Clin Cancer Res; 2006 Jul; 12(13):4103-11. PubMed ID: 16818711
[TBL] [Abstract][Full Text] [Related]
57. Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors.
Aurisicchio L; Marra E; Luberto L; Carlomosti F; De Vitis C; Noto A; Gunes Z; Roscilli G; Mesiti G; Mancini R; Alimandi M; Ciliberto G
J Cell Physiol; 2012 Oct; 227(10):3381-8. PubMed ID: 22213458
[TBL] [Abstract][Full Text] [Related]
58. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
Asp N; Pust S; Sandvig K
Biochim Biophys Acta; 2014 Sep; 1843(9):1987-96. PubMed ID: 24747692
[TBL] [Abstract][Full Text] [Related]
59. EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells.
Grøvdal LM; Kim J; Holst MR; Knudsen SL; Grandal MV; van Deurs B
Cell Signal; 2012 Jan; 24(1):296-301. PubMed ID: 21951604
[TBL] [Abstract][Full Text] [Related]
60. ERBB3: Multifunctional enabler or primary actor in pancreatic cancer?
Landgraf R
Cancer Biol Ther; 2010 Sep; 10(6):564-6. PubMed ID: 20676043
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]